XNAS: APRE
Aprea Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for sol...
Read More
0.72
-0.04
(-5.26%)
47,730.1
XNAS Volume
XNAS 13 Mar, 2026 2:55 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Aprea Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..